MedPath

Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology

Not Applicable
Completed
Conditions
Gynecologic Cancer
Interventions
Device: LETSGO app
Registration Number
NCT03453788
Lead Sponsor
Sorlandet Hospital HF
Brief Summary

This pilot study is evaluating a new smartphone application named the LETSGO app. The LETSGO app is designed to promote empowerment in patients after treatment for gynecological cancer.

Detailed Description

Gynecological cancer treatment is increasingly successful, resulting in a rising number of cancer survivors. Many gynecological cancer survivors may experience late side effects from their cancer treatment. In addition, evidence is accumulating that an active lifestyle may increase empowerment and may positively influence well-being after cancer treatment. Through the LETSGO smartphone app, women treated for gynecological cancer will get access to individualized posttreatment information on side effects as well as tailored physical activity advices in order to assume more responsibility for achieving the best outcomes from her care. The participants will also regularly answer patient reported outcomes regarding possible recurrence though the app. As a first step the smart-phone application will be pilot-tested.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Patients diagnosed and treated for gynecological cancer who will be followed up at the gynecological outpatient clinic in Kristiansand or Arendal
  • No cognitive barriers.
Exclusion Criteria
  • < 18 years
  • Not able to read Norwegian

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupLETSGO appAlternating follow-up visits by nurse and doctor. In the nurse-led consultations, the patients will be introduced to the smartphone LETSGOapp with access to information on cancer treatment and side effects, physical activity advice. Two-monthly assessment of 12 symptoms that may represent relapse through the app.The patients will fill in an electronic questionnaire package at baseline, 3, and 6 months after treatment.
Primary Outcome Measures
NameTimeMethod
Satisfaction with LETSGOapp8 months

Evaluate satisfaction with app through patient interviews

Secondary Outcome Measures
NameTimeMethod
Acceptability of goal setting8 months

Evaluate acceptability of goalsetting through changes in Activity level

Recruitment rate6 months

Evaluate the patient recruitment rate

Trial Locations

Locations (1)

Sorlandet Hospital

🇳🇴

Kristiansand, Vest Agder, Norway

© Copyright 2025. All Rights Reserved by MedPath